Abbonarsi

Human milk oligosaccharide profiles and allergic disease up to 18 years - 04/03/21

Doi : 10.1016/j.jaci.2020.06.027 
Caroline J. Lodge, PhD a, b, , Adrian J. Lowe, PhD a, b, Elasma Milanzi, PhD a, Gayan Bowatte, PhD a, c, d, Michael J. Abramson, PhD e, Helen Tsimiklis, BSc(Hons) f, Christine Axelrad, RN b, Bianca Robertson, MS g, Aaron E. Darling, PhD h, Cecilie Svanes, PhD i, Matthias Wjst, MD j, k, Shyamali C. Dharmage, PhD a, b, , Lars Bode, PhD g,
a Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia 
b Murdoch Childrens Research Institute, Royal Childrens Hospital, Parkville, Australia 
c Department of Basic Sciences, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya, Sri Lanka 
d National Institute of Fundamental Studies, Kandy, Sri Lanka 
e School of Public Health & Preventive Medicine, Monash University, Melbourne, Australia 
f Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia 
g Department of Pediatrics and Larsson-Rosenquist Foundation Mother-Milk-Infant Center of Research Excellence, University of California San Diego, La Jolla, Calif 
h The ithree Institute, University of Technology Sydney, Ultimo, Australia 
i Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway 
j Institute of Lung Biology and Disease, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health (GmbH), Neuherberg, Germany 
k Institut für Medizinische Informatik Statistik und Epidemiologie, Lehrstuhl für Medizinische Informatik, Klinikum rechts der Isar, Munich, Germany 

Corresponding author: Caroline J. Lodge, PhD, University of Melbourne, 207 Bouverie St, Victoria 3010, NSW, Australia.University of Melbourne207 Bouverie StVictoriaNSW3010Australia

Abstract

Background

Human milk oligosaccharides (HMO) are a diverse range of sugars secreted in breast milk that have direct and indirect effects on immunity. The profiles of HMOs produced differ between mothers.

Objective

We sought to determine the relationship between maternal HMO profiles and offspring allergic diseases up to age 18 years.

Methods

Colostrum and early lactation milk samples were collected from 285 mothers enrolled in a high-allergy-risk birth cohort, the Melbourne Atopy Cohort Study. Nineteen HMOs were measured. Profiles/patterns of maternal HMOs were determined using LCA. Details of allergic disease outcomes including sensitization, wheeze, asthma, and eczema were collected at multiple follow-ups up to age 18 years. Adjusted logistic regression analyses and generalized estimating equations were used to determine the relationship between HMO profiles and allergy.

Results

The levels of several HMOs were highly correlated with each other. LCA determined 7 distinct maternal milk profiles with memberships of 10% and 20%. Compared with offspring exposed to the neutral Lewis HMO profile, exposure to acidic Lewis HMOs was associated with a higher risk of allergic disease and asthma over childhood (odds ratio asthma at 18 years, 5.82; 95% CI, 1.59-21.23), whereas exposure to the acidic-predominant profile was associated with a reduced risk of food sensitization (OR at 12 years, 0.08; 95% CI, 0.01-0.67).

Conclusions

In this high-allergy-risk birth cohort, some profiles of HMOs were associated with increased and some with decreased allergic disease risks over childhood. Further studies are needed to confirm these findings and realize the potential for intervention.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Human milk oligosaccharides, allergy, childhood, latent class analysis

Abbreviations used : CHILD, DSLNT, HMO, LCA, LSTc, MACS, 6’SL


Mappa


 This work was funded by the Asthma Australia and the National Health and Medical Research Council of Australia. None of the work was directed by or influenced by these institutions.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2020  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 3

P. 1041-1048 - Marzo 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Shared DNA methylation signatures in childhood allergy: The MeDALL study
  • Cheng-Jian Xu, Olena Gruzieva, Cancan Qi, Ana Esplugues, Ulrike Gehring, Anna Bergström, Dan Mason, Leda Chatzi, Daniela Porta, Karin C. Lodrup Carlsen, Nour Baïz, Anne-Marie Madore, Harri Alenius, Bianca van Rijkom, Soesma A. Jankipersadsing, Pieter van der Vlies, Inger Kull, Marianne van Hage, Mariona Bustamante, Aitana Lertxundi, Matias Torrent, Gillian Santorelli, Maria Pia Fantini, Vegard Hovland, Giancarlo Pesce, the BIOS Consortium, Nanna Fyhrquist, Tiina Laatikainen, Martijn C. Nawijn, Yang Li, Cisca Wijmenga, Mihai G. Netea, Jean Bousquet, Josep M. Anto, Catherine Laprise, Tari Haahtela, Isabella Annesi-Maesano, Kai-Håkon Carlsen, Davide Gori, Manolis Kogevinas, John Wright, Cilla Söderhäll, Judith M. Vonk, Jordi Sunyer, Erik Melén, Gerard H. Koppelman
| Articolo seguente Articolo seguente
  • Microbiome-induced antigen-presenting cell recruitment coordinates skin and lung allergic inflammation
  • Niki D. Ubags, Aurélien Trompette, Julie Pernot, Britt Nibbering, Nicholas C. Wong, Céline Pattaroni, Alexis Rapin, Laurent P. Nicod, Nicola L. Harris, Benjamin J. Marsland

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.